What You Should Know:– Nebraska-based Bluestem Health today announced it has launched an AI-based virtual medical assistant powered by Mediktor. This is available for both established and non-established patients to efficiently assess their symptoms…
Continue Reading
What You Should Know:– AGS Health, a provider for tech-enabled revenue cycle management (RCM) solutions announces the acquisition of the India-based patient access outsourcing business unit of the Florida-based healthcare technology company Availity.– With more…
Continue Reading
It’s a well documented fact that cancer screening rates went down during the pandemic, after offices had to defer patient access to preventive screenings to both preserve the medical workforce and keep patients socially…
Continue Reading
Tillmann Schwabe, General Manager of Everphone U.S.The Great Resignation changed how companies approach attracting and retaining talent. These days, it’s not enough to offer a competitive salary and traditional benefits like health insurance…
Continue Reading
Happy President’s Day!
I hope that each of you has had a wonderful holiday. A massive thank you to all of those in healthcare who are still working on the holiday.
I thought this quote from…
Zero Trust and NIST SP 800-207The National Institutes of Standards and Technology brought private and public partnerships together to discuss how to develop a framework to defend against attacks. On Aug. 11, 2020, NIST…
Continue Reading
When the COVID-19 pandemic hit in early 2020 and everything shut down, it became imperative for healthcare provider organizations to adopt telemedicine to deliver care. But so many organizations had no telemedicine programs, and thus technology, in place.So, many provider organizations scrambled and turned to what they could. And in so…
Continue Reading
Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…
Continue Reading
Pharmacy Benefit Managers (PBMs) took a hit from lawmakers during a Thursday hearing held by the Senate Commerce Committee, with some questioning why the drug middlemen are even necessary.
“The way I see the situation on PBMs, I don’t know why the hell they even exist,” said Sen. Jon Tester, D-Montana. “They were set up with all the right reasons … But what I see them doing in my state, I don’t think the consumer gets much benefit and they’re shutting down small businesses on main street right and left and those are called our local neighborhood pharmacies.” The hearing discussed how…
The challenges of designing effective clinical trials, finding the right people to participate in them and building trial cohorts that are representative of the population at large, have been well-documented.With its recent Life Sciences initiative, Epic has set its sights on data-driven insights to improve the development of new therapeutics and interventions. That includes improving all parts of the clinical trial process – from how physicians educate their patients about potential cohorts, matching and connecting patients with promising research and helping make sure those studies are optimally beneficial for as many people as possible. Epic is already helping its provider customers…
Continue Reading
